blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2764350

EP2764350 - SRM/MRM ASSAY FOR THE FATTY ACID SYNTHASE PROTEIN [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  19.06.2020
Database last updated on 02.11.2024
FormerRequest for examination was made
Status updated on  22.02.2017
Most recent event   Tooltip19.06.2020Withdrawal of applicationpublished on 22.07.2020  [2020/30]
Applicant(s)For all designated states
Expression Pathology, Inc.
9600 Medical Center Drive, Suite 300
Rockville, MD 20850 / US
[N/P]
Former [2016/01]For all designated states
Expression Pathology, Inc.
9600 Medical Center Drive Suite 300
Rockville MD 20850 / US
Former [2014/33]For all designated states
Expression Pathology, Inc.
9620 Medical Center Drive
Suite 100
Rockville, MD 20850 / US
Inventor(s)01 / KRIZMAN, David, B.
24305 Welsh Road
Gaithersburt, MD 20882 / US
02 / HEMBROUGH, Todd
24336 Newberry Road
Gaithersburg, MD 20882 / US
03 / THYPARAMBIL, Sheeno
3730 Singleton Terrace
Frederick, MD 21704 / US
04 / LIAO, Wei-Liao
1112 Shannon Place
Herndon, VA 20170 / US
 [2014/33]
Representative(s)AWA Sweden AB
Box 45086
104 30 Stockholm / SE
[N/P]
Former [2014/33]Bohmann, Armin K.
bohmann Anwaltssozietät Nymphenburger Strasse 1
80335 München / DE
Application number, filing date12834405.824.09.2012
WO2012US56959
Priority number, dateUS201161538091P22.09.2011         Original published format: US 201161538091 P
[2014/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013044259
Date:28.03.2013
Language:EN
[2013/13]
Type: A1 Application with search report 
No.:EP2764350
Date:13.08.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 28.03.2013 takes the place of the publication of the European patent application.
[2014/33]
Search report(s)International search report - published on:US28.03.2013
(Supplementary) European search report - dispatched on:EP06.05.2015
ClassificationIPC:G01N24/00, G01N27/62, G01N30/72, G01N33/53, G01N33/68, C12Q1/37, G01J3/00
[2014/33]
CPC:
G01N33/6848 (EP,US); G01N33/57484 (US); C12Q1/48 (EP,US);
G01N33/573 (US); G01N2333/91051 (EP,US); G01N2333/91057 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/33]
TitleGerman:SRM / MRM-TEST FÜR FETTSÄURESYNTHASEPROTEIN[2014/33]
English:SRM/MRM ASSAY FOR THE FATTY ACID SYNTHASE PROTEIN[2014/33]
French:DOSAGE SRM/MRM DE LA PROTÉINE DE L'ACIDE GRAS SYNTHASE[2014/33]
Entry into regional phase22.04.2014National basic fee paid 
22.04.2014Search fee paid 
22.04.2014Designation fee(s) paid 
22.04.2014Examination fee paid 
Examination procedure22.04.2014Examination requested  [2014/33]
13.01.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
23.03.2016Amendment by applicant (claims and/or description)
15.06.2020Application withdrawn by applicant  [2020/30]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
23.03.2016Request for further processing filed
23.03.2016Full payment received (date of receipt of payment)
Request granted
08.04.2016Decision despatched
Fees paidRenewal fee
12.09.2014Renewal fee patent year 03
11.09.2015Renewal fee patent year 04
22.09.2016Renewal fee patent year 05
26.09.2017Renewal fee patent year 06
25.09.2018Renewal fee patent year 07
24.09.2019Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2011072197  (PURDUE RESEARCH FOUNDATION [US], et al) [Y] 1-17* claims 1, 10-13 *;
 [Y]WO2011087862  (EXPRESSION PATHOLOGY INC [US], et al) [Y] 1-17 * claim - *;
 [Y]WO2011087865  (EXPRESSION PATHOLOGY INC [US], et al) [Y] 1-17 * claim - *;
 [Y]WO2011087868  (EXPRESSION PATHOLOGY INC [US], et al) [Y] 1-17 * claim - *;
 [Y]WO2011087869  (EXPRESSION PATHOLOGY INC [US], et al) [Y] 1-17 * claim - *;
 [E]WO2013166343  (NUCLEA BIOTECHNOLOGIES INC [US]) [E] 1,2,4-7,9-13,15-17 * claim - * * example 5; table 1 * * paragraph [0049] - paragraph [0050] * * paragraph [0060] * * paragraph [0019] - paragraph [0028] *
International search[Y]US2010233815  (HUNTER CHRISTIE L [US]);
 [X]US2011028344  (KRIZMAN DAVID B [US], et al);
 [X]  - ZHANG, D. ET AL., "Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.", MOL CELL PROTEOMICS., (20050726), vol. 4, no. 11, pages 1686 - 1696, XP002511246

DOI:   http://dx.doi.org/10.1074/mcp.M400221-MCP200
 [A]  - FLAVIN, R. ET AL., "Fatty acid synthase as a potential therapeutic target in cancer.", FUTURE ONCOL., (201004), vol. 6, no. 4, pages 551 - 562, XP009180004

DOI:   http://dx.doi.org/10.2217/fon.10.11
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.